NCR1 and type 1 diabetes mellitus: As for activating NK receptor presentation in T1D patients, while reduced NKp46 and NKp30 levels were observed only in patients with long-standing disease, a reduction in NKG2D was observed in both newly diagnosed and long-standing patients (72, 73).